API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/cantex-and-michigan-medicine-announce-initiation-of-a-randomized-double-blind-placebo-controlled-multicenter-phase-3-pivotal-clinical-trial-to-evaluate-the-safety-and-efficacy-of-azeliragon-in-the-treatment-of-patients-hospita-301939862.html
https://www.prnewswire.com/news-releases/cantex-and-allegheny-health-network-announce-initiation-of-a-phase-12-study-of-azeliragon-in-patients-refractory-to-first-line-treatment-of-metastatic-pancreatic-cancer-301936563.html
https://www.prnewswire.com/news-releases/cantex-pharmaceuticals-and-lenox-hill-hospital-announce-initiation-of-a-phase-2-study-of-rage-inhibitor-azeliragon-as-a-front-line-treatment-for-unmethylated-glioblastoma-301930043.html
https://www.prnewswire.com/news-releases/cantex-pharmaceuticals-announces-initiation-of-an-investigator-initiated-phase-2-clinical-trial-investigating-azeliragon-combined-with-stereotactic-radiosurgery-for-the-treatment-of-brain-metastases-301911475.html
https://www.prnewswire.com/news-releases/cantex-and-michigan-medicine-announce-initiation-of-a-randomized-double-blind-placebo-controlled-phase-23-clinical-study-to-determine-the-safety-and-efficacy-of-azeliragon-in-the-treatment-of-patients-hospitalized-for-covid-19-301802539.html
https://www.prnewswire.com/news-releases/cantex-and-miami-cancer-institute-announce-fda-clearance-for-a-clinical-trial-investigating-azeliragon-combined-with-stereotactic-radiosurgery-for-the-treatment-of-brain-metastases-301762892.html
https://www.prnewswire.com/news-releases/cantex-pharmaceuticals-receives-fda-orphan-drug-designation-for-azeliragon-for-the-treatment-of-glioblastoma-301716178.html
https://www.pharmaceutical-technology.com/news/cantex-drug-inflammatory-lung-diseases/
https://www.prnewswire.com/news-releases/cantex-to-expand-development-of-its-drug-azeliragon-collaborating-with-harvards-wyss-institute-as-a-treatment-of-covid-19-and-other-inflammatory-lung-diseases-301490047.html
https://www.globenewswire.com/news-release/2021/06/22/2250877/0/en/vTv-Therapeutics-and-Cantex-Pharmaceuticals-Announce-Strategic-Licensing-Agreement-for-Development-and-Commercialization-of-Azeliragon-for-Treatment-of-Cancer.html